domingo, 8 de febrero de 2015

Functional Genomics & Predictive Medicine Overview

Functional Genomics & Predictive Medicine Overview

trans drug discovery

Dear Colleague,

We welcome you to GTCbio's Functional Genomics & Predictive Medicine Conference, which is part of The Pan-Omics Summit and takes place on May 21 - 22, 2015 in Boston, MA.

Understanding genetic variation in human diseases is vital to providing the most up-to-date procedures in a clinical setting. Recent developments in gene targeting technology provides crucial information in target validation for therapeutic applications in the areas of inflammation, oncology, immunology, and infectious diseases. However, the more tedious task at hand is incorporating data from assays and technologies and integrating basic principles of genomics, systems biology, engineering, etc.

This meeting focuses on understanding the specific cellular events that occur on the levels of transcription, translation, and protein-protein interactions. Speakers will present on mutations that are controlled at the level of DNA and how they are predictors for the change in function and structure in downstream products. We will take a closer look at genomic variation in relation to predicting a patient's response to drugs and applications for clinical advantages. 

Session topics include:

I. Molecular Diagnostics and Therapeutic Application for Rare and Common Disorders
II. Approaches for Analyses and Integration of Complex Data

III. Understanding Genomic Variation at the Cellular Level
IV. Understanding Genomic Variation in Three Dimensions: Impact on Protein-Protein and Protein-Drug Interactions
Dedicated networking sessions will allow opportunities for intimate discussions and building relationships. We hope to see you in Boston for a rich exchange of ideas and updates!

Best regards,

The 2015 Advisory Committee

Scientific Advisory Board Members
Jingfang Ju, Stony Brook University School of MedicineHakon Hakonarson, Children's Hospital of Philadelphia
Paul Billings, Thermo Fisher ScientificJeff Boyd, Fox Chase Cancer Center
Ruth Loos, Icahn School of Medicine at Mount SinaiBruce Korf, University of Alabama at Birmingham
Emanuel Petricoin, George Mason UniversityPeter Tolias, Stevens Institute of Technology
Debraj GuhaThakurta, Dendreon CorporationDaniela Starcevic, Icahn School of Medicine at Mount Sinai
Stephen Burley, Lilly Biotechnology CenterYijun Ruan, Jack Laboratory Genomic Medicine
Peter Myler, Seattle Biomedical Research InstituteJohn Martignetti, Icahn School of Medicine at Mount Sinai

No hay comentarios: